MARK A SR PRYGOCKI
CIK 1257544 · President · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.86M
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$5.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | Director | — | $5.73 | — | $0 | 10 | 2026-06-09 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Director | 5,766 | $0.01 | $78 | $0 | 2 | 2022-06-09 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | — | $3.65 | — | $0 | 2 | 2016-05-09 |
| MRX | President | 304,453 | $61.96 | $18.86M | -$5.67M | 27 | 2012-04-05 |
Recent Filings · Page 5 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-08 | MRX | Grant (A) | +42,457 | $0 | EDGAR |
| 2007-03-09 | MRX | Grant (A) | +25,487 | $0 | EDGAR |
Showing 41–42 of 42
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.